We then performed similar experiments using two MDS/AML cells that we established previously: cRAM (combined expression of RUNX1 and ASXL1 Mutations)21 and cSAM (combined expression of SETBP1 and ASXL1 Mutations)22,23 cells. This evidence concerns the gene ASXL1 and myelodysplastic syndrome.